Filter
262
Filtered Results: 262
Text search:
Viral
Haemorrhagic
Fevers
Featured
Recommendations
54
New Publications
88
Language
Document type
No document type
162
Guidelines
46
Manuals
20
Studies & Reports
17
Strategic & Response Plan
8
Training Material
3
Fact sheets
3
Situation Updates
2
Online Courses
1
Countries / Regions
Liberia
31
Sierra Leone
29
Nigeria
18
Guinea
13
Ghana
12
Uganda
8
Global
8
Congo, Democratic Republic of
7
Rwanda
7
Western and Central Europe
7
Burkina Faso
6
India
6
Kenya
6
Mali
5
Côte d’Ivoire / Ivory Coast
5
South Africa
5
Africa
5
Senegal
4
Philippines
4
Tanzania
4
Bangladesh
4
West and Central Africa
4
Ethiopia
3
Niger
3
Nepal
3
Chad
3
East and Southern Africa
3
Cameroon
2
Togo
2
Germany
2
Ukraine
2
Myanmar / Burma
2
Middle East and North Africa
2
Latin America and the Carribbean
2
Guinea-Bissau
1
Saudi Arabia
1
Zimbabwe
1
Somalia
1
South Sudan
1
Afghanistan
1
Syria
1
Mauritania
1
Benin
1
Central African Republic
1
Namibia
1
North Macedonia
1
Lesotho
1
Yemen
1
South–East Asia Region
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
81
Clinical Guidelines
39
Key Resources
21
Public Health
15
Capacity Building
8
Women & Child Health
8
Pharmacy & Technologies
5
Toolboxes
Ebola
83
Rapid Response
51
COVID-19
14
AMR
11
Pharmacy
11
NTDs
11
Specific Hazards
7
Zika
6
Conflict
4
Caregiver
4
Global Health Education
3
Planetary Health
3
Natural Hazards
2
Cholera
1
Refugee
1
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral ... disease that poses a challenge for health professionals. It requires early recognition of signs and symptoms, which are often nonspecific, and it can mimic other acute febrile syndromes. Early detection of suspected or confirmed cases, monitoring of vital signs, life support measures, and treatment of acute kidney failure continue to be the recommended strategies for case management. This report is the result of discussions among experienced specialists in the Americas on the clinical management of yellow fever patients, especially during outbreaks and epidemics, in the context of current medical and scientific evidence and taking into account the technical guidelines already available in the countries of the Region. It includes flowcharts for initially addressing patients with clinical suspicion of yellow fever and proposes a minimum package of laboratory tests that may be useful in contexts where resources are limited. In addition, it considers aspects of health system organization for dealing with yellow fever outbreaks and epidemics.
Leptospirosis is a zoonotic disease with epidemic potential, especially after a heavy rainfall,
caused by a bacterium called Leptospira. Leptospira interrogans is pathogenic to humans and
animals, with more than 200 serologic variants or serovars. Humans usually acquire
leptospirosis through dire...
PLoS ONE 7(12): e52986. doi:10.1371/journal.pone.0052986. Opern Access please download from the website
Revised and expanded version of the Guidelines
Travelers planning to conduct humanitarian work in areas where outbreaks of Ebola hemorrhagic fever and Marburg hemorrhagic fever are known to occur need to be familiar with how Ebola virus and Marb...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
Rapid Advice Guideline
The Journal of Infectious Diseases, jiy435, https://doi.org/10.1093/infdis/jiy435.
Many outbreaks reported high proportions of infected HWs. Similar HW infection rates and exposure risk factors in both past and recent EVD and MVD outbreaks emphasize the need to improve the implementation of approp...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
